Eric Poma
Chief Executive Officer at MOLECULAR TEMPLATES, INC.
Net worth: 29 611 $ as of 29/04/2024
Eric Poma active positions
Companies | Position | Start | End |
---|---|---|---|
MOLECULAR TEMPLATES, INC. | Director/Board Member | 31/12/1999 | - |
Chief Executive Officer | 31/12/1999 | - | |
Chief Tech/Sci/R&D Officer | 31/12/1999 | - | |
Founder | 31/12/1999 | - | |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Director/Board Member | - | - |
Chief Executive Officer | - | - |
Career history of Eric Poma
Former positions of Eric Poma
Companies | Position | Start | End |
---|---|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 31/12/2000 | - |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | 28/02/2005 | - |
Corporate Secretary | 28/02/2005 | 24/10/2013 |
Training of Eric Poma
The Leonard N Stern School of Business | Masters Business Admin |
University of North Carolina at Chapel Hill | Doctorate Degree |
Statistics
International
United States | 7 |
Operational
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Private companies | 3 |
---|---|
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |
- Stock Market
- Insiders
- Eric Poma
- Experience